Discovery Of New Genetic Biomarkers May Pave The Way For A Lab Test For Bipolar Spectrum Disorder Within Three Years

Dr Andy Zamar, Medical Director of TLPC, says: "We are very excited about these findings and have commissioned King's College London (KCL) to conduct an independent replication study. We may well be 24-36 months away from a diagnostic lab test for bipolar spectrum disorder. DrAndy Zamar, Medical Director of TLPC, says: "We are very excited about these findings and have commissioned King's College London (KCL) to conduct an independent replication study. We may well be 24-36 months away from...

Dr Andy Zamar, Medical Director of TLPC, says: "We are very excited about these findings and have commissioned King's College London (KCL) to conduct an independent replication study. We may well be 24-36 months away from a diagnostic lab test for bipolar spectrum disorder.

"It takes an average of 13 years to diagnose bipolar disorders in the UK with the majority (the subthreshold form), remaining undiagnosed for life. Patients are often prescribed antidepressants which make the condition worse. We hope the results of this paper lead to a test for bipolar spectrum disorder and enables not only accurate and speedy diagnosis, but ensures patients don't suffer the impacts of misdiagnosis and mistreatment."

TLPC has a pending patent for the first potential laboratory test for bipolar spectrum disorder. TLPC is known for its pioneering work and inventions in psychiatry. It has introduced many new technologies to the UK and Europe, including the combination of rTMS and thyroid hormones in the treatment of bipolar spectrum disorder.

For more information contact The London Psychiatry Centre: info@psychiatrycentre.co.uk

View original content:https://www.prnewswire.co.uk/news-releases/discovery-of-new-genetic-biomarkers-may-pave-the-way-for-a-lab-test-for-bipolar-spectrum-disorder-within-three-years-301873338.html